Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: NicholasC who wrote (7554)	4/29/1998 6:34:00 PM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

NicholasC...1997 Muse Script History__________________________________ is published in message #5652 .....

To: NicholasC who wrote (7554)	4/29/1998 8:57:00 PM
From: al	Respond to of 23519

Insurance coverage: Front page NY Times this am 04/29.98. Reported on 6:30 pm (EST) CBS News - Dan Rather. " : " " NBC News - Tom Brokaw. 25% gustimate on percentage of Viagra faailures to try the next acceptable, FDA approved product. I assume 75% Viagra failures will not go forward, they will be fatalistic. Balance will have been drawn to possible relief, alone or with significant other's push/nagging/pleading/entreaty. Note: My percentage of Muse tryers from Viagra failures (and there will be Viagra failures), is arbitrary on my part!!! Could be more, could be less. My percentage of Viagra failures is based on most of the previous posts from February '98 till now. Cutting me a little slack with the numbers, i.e. 200,000 new "patients" would give Vivus approximately 15,000 presrcptions per week... triple the amount just before Viagra Debut. I really believe the "new Patient" count will exceed 350,000 in the first 60 days of Viagra availability, especially given the massive TV & Print exposure now occuring. So, I believe that all of my favorable assumptions on the side of increased Muse usage are Conservative. Please continue this dialog.